| Structure of compound 1 bound to SARS-CoV-2 main protease | | homo-2-mer | 3264-3569 | 100.0 | 2×A1IVK; 4×EDO; 3×BR; 1×NA; |
|
| Structure of compound 119 bound to SARS-CoV-2 main protease | | homo-2-mer | 3264-3569 | 100 | 2×A1ITI; 1×CL; 1×NA; |
|
| CRYSTAL STRUCTURE OF THE SARS-COV-2 MAIN PROTEASE COMPLEXED WITH FRAGMENT F01 | | homo-2-mer | 3264-3569 | 100 | 4×NA; 4×DMS; 2×5P9; |
|
| Crystal structure of SARS-CoV-2 Mpro in complex with cyclic peptide GM4 including unnatural amino a… | | homo-2-mer | 3264-3569 | 100 | 2×PEG; 1×DMS; 2×EDO; 1×PGE; |
|
| SARS-CoV-2 Mpro (Omicron, P132H+T169S) in complex with alpha-ketoamide 13b-K | | homo-2-mer | 3264-3569 | 99.35 | 2×O6K; |
|
| SARS-CoV-2 Main protease bound to a non-covalent non-peptidic HTS hit | | homo-2-mer | 3264-3569 | 100 | 4×DMS; 3×EDO; 1×SO4; 2×A1A21; 2×A1AFD; 1×GOL; |
|
| SARS-CoV-2 Mpro (Omicron, P132H+T169S) free enzyme | | homo-2-mer | 3264-3569 | 99.35 | |
|
| Crystal structure of SARS-CoV-2 Mpro with compound 12 | | homo-2-mer | 3264-3569 | 100 | 2×A1IL7; 7×SO4; 5×GOL; 2×EDO; |
|
| Structure of SARS-CoV-2 Mpro in complex with its degrader | | homo-2-mer | 3264-3569 | 100 | 2×A1LYZ; |
|
| Crystal structure of SARS-CoV-2 Mpro with AB-343. | | homo-2-mer | 3264-3569 | 100 | 2×A1IMY; 1×CL; 2×PEG; 2×EDO; |
|
| Crystal Structure of SARS-CoV-2 Main Protease (Mpro) T21I Mutant | | homo-2-mer | 3264-3569 | 99.67 | |
|
| Crystal structure of the Mpro of SARS COV-2 in complex with the MG-87 inhibitor | | homo-2-mer | 3264-3569 | 100 | 2×MXU; 1×CL; |
|
| Crystal Structure of SARS-CoV-2 Main Protease (Mpro) L50F/E166A/L167F Triple Mutant | | homo-2-mer | 3264-3569 | 99.02 | |
|
| Crystal structure of SARS-CoV-2 Main Protease (Mpro) with covalent inhibitor 5,8-Dihydroxy-1,4-naph… | | homo-2-mer | 3264-3569 | 100.0 | 2×PEG; 1×X7F; 1×DMS; |
|
| Crystal Structure of T21I SARS-CoV-2 Main Protease in Complex with Nirmatrelvir | | homo-2-mer | 3264-3568 | 99.67 | 2×4WI; |
|
| SARS-CoV-2 Mpro (Omicron,P132H) in complex with alpha-ketoamide 13b-K at pH 8.5 | | homo-2-mer | 3264-3568 | 99.67 | 2×O6K; 1×CL; |
|
| SARS-CoV-2 3CL protease (3CLpro) in complex with compound JZD-122 | | homo-2-mer | 3264-3567 | 100 | 2×A1D50; |
|
| SARS-COV2 Main Protease in complex with inhibitor MG-131 | | homo-2-mer | 3264-3567 | 100 | 2×I8H; 2×NA; |
|
| SARS-CoV-2 Mpro in Complex with RK-107 | | homo-2-mer | 3264-3567 | 100 | 2×A1IMU; |
|
| Crystal structure of SARS-CoV-2 Mpro with compound 5 | | homo-2-mer | 3264-3566 | 100 | 2×A1IL0; |
|
| Crystal structure of SARS-Cov-2 main protease K90R mutant in complex with X77 | | homo-2-mer | 3265-3567 | 99.67 | 2×X77; |
|
| Crystal Structure of T21I SARS-CoV-2 Main Protease | | homo-2-mer | 3264-3566 | 99.67 | |
|
| Crystal Structure of T21I SARS-CoV-2 Main Protease in Complex with Compound Mpro61 | | homo-2-mer | 3264-3566 | 99.67 | 1×XEK; |
|
| Crystal structure of the SARS-CoV-2 main protease in complex with SY110 | | homo-2-mer | 3264-3566 | 99.67 | 2×LVX; |
|
| SARS-CoV-2 3CL protease (3CLpro) in complex with compound JZD-128 | | homo-2-mer | 3264-3565 | 100 | 2×A1D51; |
|
| SARS-CoV-2 3CL protease (3CL pro) in complex with a novel inhibitor | | homo-2-mer | 3264-3564 | 100 | 2×A1D70; |
|
| SARS-COV2 Main Protease in complex with inhibitor MG78 | | homo-2-mer | 3264-3564 | 100 | 2×I70; 2×CL; 4×NA; |
|
| Crystal structure of the SARS-CoV-2 main protease in complex with Hit-1 | | homo-2-mer | 3264-3564 | 100.0 | 2×LV0; 4×DMS; |
|
| Crystal structure of SARS-Cov-2 main protease in complex with X77 | | homo-2-mer | 3266-3566 | 100 | 2×X77; |
|
| Crystal structure of SARS-CoV-2 main protease in complex with C5 | | homo-2-mer | 3264-3564 | 99.67 | 2×A1LX2; |
|
| Crystal structure of SARS-Cov-2 main protease M49I mutant in complex with X77 | | homo-2-mer | 3266-3566 | 99.67 | 2×X77; |
|
| Crystal structure of SARS-CoV-2 main protease in complex with C2 | | homo-2-mer | 3264-3564 | 99.67 | 2×A1LX1; |
|
| Crystal Structure of T21I SARS-CoV-2 Main Protease in Complex with GC376 | | homo-2-mer | 3264-3563 | 99.67 | 2×UED; |
|
| Crystal structure of SARS-Cov-2 main protease, pH=6.5 | | homo-2-mer | 3266-3564 | 100 | |
|
| Crystal structure of SARS-Cov-2 main protease V186F mutant in complex with X77 | | homo-2-mer | 3266-3564 | 99.67 | 2×X77; |
|
| Crystal structure of SARS-Cov-2 main protease in complex with S217622 | | homo-2-mer | 3266-3563 | 100 | 2×7YY; |
|
| Crystal structure of SARS-Cov-2 main protease G15S mutant in complex with X77 | | homo-2-mer | 3266-3563 | 99.66 | 2×X77; |
|
| Crystal structure of SARS-Cov-2 main protease D48N mutant in complex with PF07321332 | | homo-2-mer | 3266-3563 | 99.66 | 2×4WI; |
|
| Crystal structure of SARS-Cov-2 main protease, pH=6.0 | | homo-2-mer | 3266-3563 | 100.0 | |
|
| Crystal structure of SARS-Cov-2 main protease, pH=8.5 | | homo-2-mer | 3266-3561 | 100.0 | |
|
| Crystal structure of SARS-Cov-2 main protease D48N mutant in complex with shikonin | | homo-2-mer | 3266-3561 | 99.32 | 1×FNO; |
|
| Crystal structure of SARS-Cov-2 main protease D48N mutant | | homo-2-mer | 3267-3561 | 99.66 | |
|